Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lithium Therapy in Old Age: Recommendations from a Delphi Survey.
Christl J, Müller-Oerlinghausen B, Bauer M, Kamp D, Fußer F, Benninghoff J, Fehrenbach RA, Lange-Asschenfeldt C, Rapp M, Ibach B, Schaub R, Wollmer A, Strotmann-Tack T, Hüll M, Biermann S, Roscher K, Meissnest B, Menges A, Weigel B, Maliszewski-Makowka D, Mauerer C, Schaefer M, Joachimsmeier B, Kayser S, Rump LC, Supprian T. Christl J, et al. Among authors: weigel b. Pharmacopsychiatry. 2023 Sep;56(5):188-196. doi: 10.1055/a-2117-5200. Epub 2023 Jul 28. Pharmacopsychiatry. 2023. PMID: 37506737 Free PMC article.
Correction: Lithium Therapy in Old Age: Recommendations from a Delphi Survey.
Christl J, Müller-Oerlinghausen B, Bauer M, Kamp D, Fußer F, Benninghoff J, Fehrenbach RA, Lange-Asschenfeldt C, Rapp M, Ibach B, Schaub R, Wollmer A, Strotmann-Tack T, Hüll M, Biermann S, Roscher K, Meissnest B, Menges A, Weigel B, Maliszewski-Makowka D, Mauerer C, Schaefer M, Joachimsmeier B, Kayser S, Rump LC, Supprian T. Christl J, et al. Among authors: weigel b. Pharmacopsychiatry. 2023 Sep;56(5):e1. doi: 10.1055/a-2158-9744. Epub 2023 Aug 30. Pharmacopsychiatry. 2023. PMID: 37647941 No abstract available.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Glade Bender JL, Pinkney K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Glade Bender JL, et al. Among authors: weigel bj. Oncologist. 2024 May 30:oyae096. doi: 10.1093/oncolo/oyae096. Online ahead of print. Oncologist. 2024. PMID: 38815151
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
Greengard E, Williams R, Moriarity B, Liu X, Minard CG, Reid JM, Fisher T, Evans E, Pastore DR, Zauderer M, Voss S, Fox E, Weigel BJ. Greengard E, et al. Among authors: weigel bj. Pediatr Blood Cancer. 2024 Jun;71(6):e30938. doi: 10.1002/pbc.30938. Epub 2024 Mar 23. Pediatr Blood Cancer. 2024. PMID: 38520670 Clinical Trial.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
Pilbeam KL, Pradhan K, Croop J, Minard CG, Liu X, Voss SD, Isikwei E, Berg SL, Reid JM, Fox E, Weigel BJ. Pilbeam KL, et al. Among authors: weigel bj. Pediatr Blood Cancer. 2024 Mar;71(3):e30817. doi: 10.1002/pbc.30817. Epub 2024 Jan 8. Pediatr Blood Cancer. 2024. PMID: 38189770 Clinical Trial.
195 results